Osteoporosis, Postmenopausal
Information
- Disease name
- Osteoporosis, Postmenopausal
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05395091 | Active, not recruiting | Phase 3 | Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND | August 23, 2022 | October 25, 2024 |
| NCT03931109 | Active, not recruiting | Circulating miRNA in Primary Hyperparathyroidism | September 7, 2018 | July 2024 | |
| NCT03227458 | Active, not recruiting | N/A | DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women | February 12, 2018 | June 2024 |
| NCT03692143 | Active, not recruiting | Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP | January 1, 2017 | December 1, 2030 | |
| NCT06375668 | Active, not recruiting | N/A | The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women | March 15, 2022 | June 15, 2024 |
| NCT05405894 | Active, not recruiting | Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation | September 1, 2022 | July 1, 2025 | |
| NCT03623633 | Active, not recruiting | Phase 4 | Comparative Antiresorptive Efficacy Discontinuation of Denosumab | November 30, 2018 | August 1, 2023 |
| NCT05853354 | Active, not recruiting | Phase 3 | Comparative Efficacy, Safety, PK, and Immunogenicity Study | April 5, 2023 | December 30, 2025 |
| NCT00191425 | Completed | Phase 4 | 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis | August 2002 | November 2005 |
| NCT00222872 | Completed | Phase 1 | 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women | July 2005 | September 2008 |
| NCT00271713 | Completed | Phase 4 | Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) | March 2006 | September 2007 |
| NCT00343252 | Completed | Phase 3 | Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis | June 2006 | June 2010 |
| NCT00351091 | Completed | Phase 2 | Risedronate in Postmenopausal Women With Low Bone Density | November 2002 | June 2003 |
| NCT00353080 | Completed | Phase 3 | Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women | December 2002 | April 2005 |
| NCT00357331 | Completed | Phase 4 | The Effects of Potassium Citrate on Bone Metabolism | August 2006 | April 2011 |
| NCT00383422 | Completed | Phase 3 | Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis | October 2006 | July 2008 |
| NCT00389740 | Completed | Phase 3 | A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) | April 2, 2001 | January 16, 2003 |
| NCT00398606 | Completed | Phase 3 | A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) | April 1995 | |
| NCT00398931 | Completed | Phase 3 | FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) | February 1998 | October 2003 |
| NCT00402441 | Completed | Phase 4 | Risedronate in the Prevention of Osteoporosis in Postmenopausal Women | September 2002 | June 2004 |
| NCT00405392 | Completed | Phase 4 | Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis | March 22, 2007 | May 27, 2008 |
| NCT00453492 | Completed | Phase 4 | Risedronate Sodium in Post Menopausal Osteoporosis | January 2004 | |
| NCT00542984 | Completed | Phase 3 | Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis | August 2003 | November 2004 |
| NCT00549068 | Completed | Phase 4 | POWER Point of Care Effect on Satisfaction of Treatment | February 2003 | November 2004 |
| NCT00549965 | Completed | Phase 4 | Satisfaction and Compliance of Risedronate in PMO | October 2003 | |
| NCT00557310 | Completed | Phase 4 | A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide | November 2007 | May 2011 |
| NCT00591747 | Completed | N/A | Strength Training for Older Breast Cancer Survivors | November 2005 | June 2011 |
| NCT00632216 | Completed | Phase 4 | A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis | May 2004 | May 2006 |
| NCT00659906 | Completed | N/A | Optimizing Body Composition & Health After Breast Cancer | January 2006 | January 2009 |
| NCT00670319 | Completed | Phase 3 | Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis | November 1994 | September 1999 |
| NCT00670501 | Completed | Phase 3 | Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis | August 1996 | April 1999 |
| NCT00696644 | Completed | A Study for Teriparatide in Severe Osteoporosis | June 2008 | April 2011 | |
| NCT00959764 | Completed | Phase 3 | A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women | June 2009 | February 2011 |
| NCT00965978 | Completed | Phase 1 | A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation | July 2009 | September 2009 |
| NCT01064453 | Completed | Angeliq Regulatory Post Marketing Surveillance | June 2007 | December 2012 | |
| NCT01227369 | Completed | Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment | June 2008 | November 2009 | |
| NCT01250145 | Completed | Phase 1 | A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women | November 2010 | May 2011 |
| NCT01350934 | Completed | Phase 4 | A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) | June 19, 2011 | January 10, 2013 |
| NCT01381588 | Completed | The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women | October 2010 | February 2011 | |
| NCT01386281 | Completed | Julina Post-marketing Surveillance for Climacteric Symptoms in Japan | October 20, 2008 | April 15, 2014 | |
| NCT01397955 | Completed | Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan | January 2009 | April 2014 | |
| NCT01401114 | Completed | Wellnara Post-marketing Surveillance in Japan | March 2009 | September 2014 | |
| NCT01416194 | Completed | Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU) | July 25, 2011 | April 30, 2019 | |
| NCT01457950 | Completed | Phase 3 | A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab | November 2011 | June 2013 |
| NCT01495000 | Completed | Phase 3 | A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab | January 2012 | February 2013 |
| NCT01571843 | Completed | N/A | Radius Loading in Primary Hyperparathyroidism | February 2010 | October 2014 |
| NCT01652690 | Completed | Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice | June 26, 2012 | May 15, 2015 | |
| NCT01881204 | Completed | N/A | Hesperidin and Bone Health in Postmenopausal Women | April 2011 | October 2012 |
| NCT02014467 | Completed | Phase 3 | Denosumab China Phase III Study | January 2014 | August 2015 |
| NCT02090400 | Completed | Phase 4 | Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women | May 2013 | July 2015 |
| NCT02109042 | Completed | Phase 1 | A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants | April 2014 | July 2014 |
| NCT02157753 | Completed | Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma Center | July 2012 | December 2015 | |
| NCT02247011 | Completed | N/A | A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal Women | March 2013 | May 2016 |
| NCT02416947 | Completed | N/A | Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women | March 2012 | January 2015 |
| NCT02472782 | Completed | Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication | May 2015 | December 15, 2018 | |
| NCT02589600 | Completed | Phase 4 | Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II) | January 2016 | June 22, 2022 |
| NCT02753283 | Completed | Phase 4 | Preventing Osteoporosis Using Denosumab | June 2016 | August 2023 |
| NCT02884401 | Completed | N/A | Peri-implant Bone Changes in Post-menopausal Osteoporotic Women | September 2016 | August 30, 2022 |
| NCT03091088 | Completed | N/A | Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women | February 1, 2011 | December 30, 2016 |
| NCT03125590 | Completed | Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ) | April 1, 2017 | August 11, 2017 | |
| NCT03268356 | Completed | N/A | STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture | August 15, 2017 | December 31, 2020 |
| NCT03304743 | Completed | Dental Panoramic Radiographs to Screen for Post-menopausal Osteoporosis | June 12, 2018 | January 7, 2021 | |
| NCT03367585 | Completed | N/A | Effects of Vitamin D Supplementation in Muscle Strength and Balance Training | February 1, 2018 | April 22, 2020 |
| NCT00010712 | Completed | Phase 2 | Effects of Black Cohosh on Menopausal Hot Flashes | September 1999 | July 2005 |
| NCT00035256 | Completed | Phase 4 | Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis | October 2001 | July 2005 |
| NCT00046137 | Completed | Phase 3 | Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis | ||
| NCT00073190 | Completed | Phase 1 | Patient- and Physician-Based Osteoporosis Education | September 2003 | June 2006 |
| NCT00088010 | Completed | Phase 3 | Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer | June 2004 | November 2009 |
| NCT00092040 | Completed | Phase 3 | A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) | March 18, 2003 | September 28, 2005 |
| NCT00130403 | Completed | Phase 4 | OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women | March 2004 | March 2007 |
| NCT00168909 | Completed | Phase 4 | Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) | June 2003 | May 2008 |
| NCT03701113 | Completed | N/A | Milk Protein and Bone Health in Postmenopausal Women | October 22, 2018 | July 30, 2019 |
| NCT03710889 | Completed | Phase 3 | Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption | September 20, 2018 | July 15, 2020 |
| NCT03742362 | Completed | N/A | MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy Women | February 2, 2019 | December 30, 2019 |
| NCT03761979 | Completed | N/A | Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults | March 9, 2017 | July 17, 2017 |
| NCT03878732 | Completed | Bindex for Osteoporosis Diagnostics | March 11, 2019 | February 7, 2020 | |
| NCT03895333 | Completed | Hearing Loss and Osteoporosis | March 1, 2019 | March 1, 2020 | |
| NCT03910348 | Completed | N/A | Effects of Whole-Body Vibration and High Impact Exercises in Postmenopausal Women | January 2010 | September 2011 |
| NCT04029870 | Completed | Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients | June 17, 2019 | January 31, 2022 | |
| NCT04063813 | Completed | N/A | Parameters of Exercise to Prevent Osteoporosis | May 15, 2007 | August 19, 2010 |
| NCT04149405 | Completed | Phase 4 | Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis | June 30, 2016 | December 28, 2018 |
| NCT04167150 | Completed | N/A | Tart Cherry Supplementation and Women's Bone Health Study | June 6, 2017 | May 31, 2018 |
| NCT04179903 | Completed | N/A | Efficacy and Safety of the Physical Activity Program in Women With Post-menopausal Osteoporosis | February 1, 2019 | June 30, 2021 |
| NCT04206618 | Completed | Circulating Myokine Levels and Bone Metabolism | June 1, 2019 | November 10, 2020 | |
| NCT04321837 | Completed | Phase 2 | Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate | February 5, 2020 | March 13, 2023 |
| NCT04609189 | Completed | Phase 4 | Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss | July 12, 2012 | May 2, 2014 |
| NCT04729621 | Completed | Phase 3 | A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis | March 22, 2021 | June 19, 2023 |
| NCT04748029 | Completed | Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal Osteoporosis | January 1, 2021 | February 1, 2021 | |
| NCT04798313 | Completed | Phase 1 | Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults | June 2, 2020 | December 31, 2020 |
| NCT04836637 | Completed | N/A | ValoRization of Dairy Sidestreams to Fight Calcium dEficits iN Postmenopausal Women | May 17, 2021 | July 4, 2023 |
| NCT04974723 | Completed | Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women | July 1, 2021 | September 30, 2021 | |
| NCT05025917 | Completed | N/A | Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal Women | April 16, 2019 | January 17, 2020 |
| NCT05215977 | Completed | Phase 3 | Efficacy and Safety of MW031 in PMO Subjects | December 27, 2019 | September 27, 2021 |
| NCT05266261 | Completed | N/A | Use of Ibandronate in Diabetic Patients | October 1, 2018 | January 31, 2022 |
| NCT05371340 | Completed | N/A | Quercetin's Effect on Bone Health and Inflammatory Markers | August 27, 2019 | April 27, 2020 |
| NCT05372224 | Completed | N/A | Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis | June 22, 2020 | June 22, 2021 |
| NCT05559619 | Completed | N/A | Effect of Laser Acupuncture on Forearm Bone Mineral Density and Wrist Pain in Osteoporotic Postmenopausal Women | July 11, 2021 | August 6, 2022 |
| NCT05721898 | Completed | Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability | July 1, 2022 | October 30, 2023 | |
| NCT05538377 | Not yet recruiting | N/A | Effect of Focal Vibration Within a Multicomponent Exercise Program for Older Women With Osteoporosis a Single-blind Clinical Trial | December 1, 2022 | May 1, 2024 |
| NCT06462833 | Not yet recruiting | Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis | June 2024 | August 2024 | |
| NCT05688969 | Recruiting | N/A | Mechanisms of Anabolic Osteoporosis Therapy | June 14, 2023 | December 2028 |
| NCT05228262 | Recruiting | N/A | Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis | February 15, 2022 | February 1, 2027 |
| NCT05655013 | Recruiting | Phase 4 | Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2) | May 10, 2023 | February 1, 2027 |
| NCT05058976 | Recruiting | Phase 4 | Romosozumab Use to Build Skeletal Integrity | September 15, 2021 | September 2027 |
| NCT05575167 | Recruiting | Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) | November 28, 2023 | November 2026 | |
| NCT04467983 | Recruiting | Phase 4 | Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone | February 1, 2021 | June 2026 |
| NCT05493761 | Recruiting | Phase 4 | Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease | December 23, 2022 | December 2025 |
| NCT05419427 | Recruiting | Phase 3 | Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis | November 11, 2021 | November 24, 2024 |
| NCT05328154 | Recruiting | Phase 2 | MAGnesium Effect With ANtiosteoporotic Drugs | June 28, 2022 | December 31, 2024 |
| NCT06164795 | Recruiting | Sequential Therapies After Osteoanabolic Treatment | November 25, 2023 | December 2025 | |
| NCT04964388 | Recruiting | Phase 2 | Effect of GLP-1 Receptor Agonists on Trabecular Bone Score | November 9, 2021 | December 1, 2023 |
| NCT00790101 | Terminated | Phase 4 | Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation | June 2004 | October 2004 |
| NCT04469374 | Terminated | N/A | Menopause Osteoporosis and Bone Intervention Using Lifestyle Exercise. | December 1, 2019 | December 20, 2020 |
| NCT02337387 | Terminated | Phase 1 | A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women | January 2015 | March 2015 |
| NCT04271605 | Terminated | N/A | Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD) | February 14, 2020 | December 31, 2020 |
| NCT03832088 | Unknown status | N/A | Sarcopenia And Balance In Postmenopausal Osteoporosis | August 1, 2018 | March 31, 2019 |
| NCT04760145 | Unknown status | N/A | EFFECT OF FLOW RESTRICTION ON BONE QUALITY WITHIN A MULTICOMPONENT EXERCISE PROGRAM FOR OLDER WOMEN WITH OSTEOPOROSIS. | July 1, 2021 | December 1, 2021 |
| NCT03382366 | Unknown status | N/A | Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women | March 29, 2017 | May 31, 2019 |
| NCT03435094 | Unknown status | Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes | February 25, 2018 | December 1, 2022 | |
| NCT03475719 | Unknown status | Phase 1 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic | January 11, 2018 | April 30, 2018 |
| NCT03337971 | Unknown status | N/A | Nutritional Supplement and Bone Health in Post-Menopausal Women | October 3, 2017 | April 4, 2019 |
| NCT03232476 | Unknown status | Phase 4 | Effect of Mechanical Loading With PTH on Cortical Bone | September 2017 | December 2019 |
| NCT04864509 | Unknown status | Phase 4 | The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressure | May 1, 2021 | June 1, 2024 |
| NCT03832075 | Unknown status | N/A | Validity of Korebalance Balance System | August 1, 2018 | February 28, 2019 |
| NCT02630797 | Unknown status | Phase 1/Phase 2 | Effect of Blueberries on Bone Turnover | January 12, 2017 | August 2019 |
| NCT03225703 | Unknown status | N/A | The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women | January 2017 | January 2019 |
| NCT04019938 | Unknown status | Association of Cystatin C and Bone Mineral Density in Diabetic Patients. | July 4, 2019 | December 25, 2019 | |
| NCT03158246 | Unknown status | Phase 4 | Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women | June 1, 2017 | March 2, 2020 |
| NCT05402852 | Unknown status | Phase 4 | Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women | June 1, 2022 | December 31, 2023 |
| NCT03812367 | Withdrawn | Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid | January 1, 2019 | December 31, 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015663